Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study.

Cancers (Basel) · 2023 · PMC10526312 · PMID 37760555

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an evident trendno p-value reported

However, an evident trend was observed.

also in 70 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.